VentriPoint Diagnostics Ltd V.VPT

EuropeV4.0 at any time!🚀 Sales Mayo Clinic?Insiders know!😎

[jopatclo]

GranhamB the vulture Remember good comment @cardinal When the biggest in the world buy, everyone buys...
& and  the photo of Hugh and company on the tiles in the lobby of a building. Which was geo located to be the Mayo Clinic.
Remenber! Where has Hugh been lately Hugh in London maybe news Collaborations or Partnerships ? Very excited to have next messages from Dear friends of Dr. Adams the visionary with Ventripoint. (Sales or FDA V4.0) its going up Reminder of July 5, 2023 Ventripoint Diagnostics Makes Significant Sale to the Largest Heart Center in Germany (July 4 = low 0.13 and July 24 = high 0.325 ) FDA V4.0 and Sales at any time now Insiders know!

Hugh MacNaughtHugh MacNaught • Following • FollowingPresident and CEO at Ventripoint Diagnostics Ltd.President and CEO at Ventripoint Diagnostics Ltd.1mo • 2 months ago

Working in the US midwest with Strategic Sales Manager Scott Hammerling this past week provided an excellent opportunity to meet with cardiologists and sonographers to discuss how VMS+ can integrate within their clinical workflows. We received positive feedback on the accuracy of RV measurements and the potential to achieve better patient compliance with scheduled studies.

• 44
• • 1 comment

Like

Comment

 

Repost

 

 

Send

 

 

 

Add a comment…

Open Emoji Keyboard

 

 

Current selected sort order is Most relevantMost relevant

 

Craig Galloway • 3rd+

Gorman Bros. Vineyard Manager

2mo

 

 

Thanks for the insight Hugh MacNaught.

I look forward to where this takes Ventripoint Diagnostics Ltd. In the coming weeks.

Hugh MacNaughtHugh MacNaught • Following • FollowingPresident and CEO at Ventripoint Diagnostics Ltd.President and CEO at Ventripoint Diagnostics Ltd.1mo • 2 months ago

Working in the US midwest with Strategic Sales Manager Scott Hammerling this past week provided an excellent opportunity to meet with cardiologists and sonographers to discuss how VMS+ can integrate within their clinical workflows. We received positive feedback on the accuracy of RV measurements and the potential to achieve better patient compliance with scheduled studies.

• 44
• • 1 comment

Like

Comment

 

Repost

 

 

Send

 

 

 

Add a comment…

Open Emoji Keyboard

 

 

Current selected sort order is Most relevantMost relevant

 

Craig Galloway • 3rd+

Gorman Bros. Vineyard Manager

2mo

 

 

Thanks for the insight Hugh MacNaught.

I look forward to where this takes Ventripoint Diagnostics Ltd. In the coming weeks.

[GrahamB]

Meh The bottom line is the biggest havent bought VPT , if you're talking about the Mayo, and even with Duke, what happened? We have not seen any significant sales yet after many many years, many many conferences, and certainly hundreds if not, thousands of posts here. I will believe it when I see it with posted sales in audited financials, certainly not some innuendo based on a picture of

[Topper00]

@GrahamB Long time long holder here and your very accurate with your posts. I been waiting so long for sales this product's been hyped for years and here we are still. Have everything in line yet where is the money and I don't want to hear it's coming insiders know it's coming you can say that about any stock doesn't make it true. We need sales end of story or trade at a level

[Topper00]

When someone floods the board so much for so long you even start to question your own investment and feel hmm what is some people's intentions to push info so much yet we have no money to show for it.  Critical thinking and reasoning  isn't allowed here or on other board I own shares in

[GrahamB]

Thanks Topper I know there are lots that read and don’t post, some who have messaged me and appreciate the evidenced based posts. Not here as much anymore-just post now and then when something is happening-which isn't much for this sad story   Really it’s been fun to analyze and wonder why after so many excuses and failed attempts this hasn’t been able to sell product.  

[jopatclo]

  I think Jeffrey Soble of Ascend cardiovascular and Beth Rumack, Chief Operating Officer Ollie Hinkle Heart Foundation FDA V4.0 and Sales at any time now Insiders know! more than the negatives that denigrate ventripoint. -“We want to introduce Ventripoint to all our hospital partners, to make it a standard of care,” Beth Rumack, Chief Operating Officer Ollie Hinkle Heart Foundation and now